# RAG Pipeline Evaluation Report

Generated: 2026-07-28T15:22:03.557925

## Summary

- Questions evaluated: 8
- Retrieval hit rate: 75.0%
- Average fact coverage: 83.4%
- Average faithfulness score: 73.8/100

## Per-Question Results

| ID | Question | Retrieval Hit | Fact Coverage | Faithfulness |
|---|---|---|---|---|
| q1 | What effect does grapefruit juice have on drug metabolism? | ✓ | 100% | 0/100 |
| q2 | How does dietary vitamin K intake interact with warfarin the | ✗ | 100% | 100/100 |
| q3 | How do GLP-1 receptor agonists affect gastric emptying and f | ✗ | 100% | 90/100 |
| q4 | What is the incidence rate of diabetic ketoacidosis among fi | ✓ | 100% | 100/100 |
| q5 | Which antidiabetic drug classes are associated with increase | ✓ | 100% | 100/100 |
| q6 | Which antidiabetic medications appear neutral or protective  | ✓ | 67% | 100/100 |
| q7 | What was the study design used to assess drug-food interacti | ✓ | 50% | 100/100 |
| q8 | How many adults with type 1 diabetes were included in the na | ✓ | 50% | 0/100 |

## Detailed Notes

### q1: What effect does grapefruit juice have on drug metabolism?
- Faithfulness judge reasoning: The sources provided do not mention the specific effect of grapefruit juice on drug metabolism or the CYP3A4 enzyme.
- Facts found: grapefruit, CYP3A4, inhibit
- Answer preview: Grapefruit juice can inhibit the CYP3A4 enzyme, which is involved in the metabolism of certain medications. This can lead to increased levels of these medications in the body, potentially causing adve...

### q2: How does dietary vitamin K intake interact with warfarin therapy?
- Faithfulness judge reasoning: The answer is directly supported by the sources as they do not mention any information about the interaction between dietary vitamin K intake and warfarin therapy.
- Facts found: vitamin K, warfarin
- Answer preview: There is no information in the provided sources about the interaction between dietary vitamin K intake and warfarin therapy....

### q3: How do GLP-1 receptor agonists affect gastric emptying and food absorption?
- Faithfulness judge reasoning: The answer is well-supported by the sources, but it does not mention the variation in effect among different GLP-1 receptor agonists or the results of specific studies like Nakatani et al. and Sen et al.
- Facts found: gastric emptying, GLP-1
- Answer preview: GLP-1 receptor agonists delay gastric emptying by inhibiting gastrointestinal motility through both peripheral nervous system (PNS) and central nervous system (CNS) mechanisms. They activate GLP-1 rec...

### q4: What is the incidence rate of diabetic ketoacidosis among first-time SGLT2 inhibitor users?
- Faithfulness judge reasoning: The answer directly quotes the incidence rate of diabetic ketoacidosis from the provided sources without any contradiction or addition of unsupported claims.
- Facts found: 24.9, 1000 person-years, ketoacidosis
- Answer preview: The incidence rate of diabetic ketoacidosis among first-time SGLT2 inhibitor users is 24.9 events per 1000 person-years.

Sources used: [1, 2, 3, 5]....

### q5: Which antidiabetic drug classes are associated with increased fracture risk?
- Faithfulness judge reasoning: The answer directly quotes the source material, accurately identifying thiazolidinediones, sulfonylurea, and some insulin regimens as antidiabetic drug classes associated with increased fracture risk.
- Facts found: thiazolidinedione, sulfonylurea
- Answer preview: Thiazolidinediones, sulfonylurea, and some insulin regimens are associated with increased fracture risk. 

Sources used: [1, 3]....

### q6: Which antidiabetic medications appear neutral or protective for bone health?
- Faithfulness judge reasoning: The answer directly quotes the source material, stating that metformin, incretin-based therapies, and sodium-glucose co-transporter 2 inhibitors appear neutral or protective for bone health.
- Facts found: metformin, incretin
- Answer preview: Metformin, incretin-based therapies, and sodium-glucose co-transporter 2 inhibitors appear neutral or protective for bone health. 

Sources used: [1, 2]....

### q7: What was the study design used to assess drug-food interaction knowledge in the nutritional counseling study?
- Faithfulness judge reasoning: The answer is directly supported by the sources, which explicitly state that the study design used was a cross-sectional study.
- Facts found: cross-sectional
- Answer preview: The study design used to assess drug-food interaction knowledge in the nutritional counseling study was cross-sectional. 

Sources used: [1, 2, 3, 4, 5]....

### q8: How many adults with type 1 diabetes were included in the nationwide Swedish cohort study on GLP-1 and SGLT2 use?
- Faithfulness judge reasoning: The answer is not supported by the sources, as the provided text does not mention the specific number of adults with type 1 diabetes included in the study.
- Facts found: 72,698
- Answer preview: 72,698 adults with type 1 diabetes were included in the nationwide Swedish cohort study on GLP-1 and SGLT2 use.

Sources used: [2, 3, 4]....

